Microcytosis in agnogenic myeloid metaplasia: Prevalence and clinical correlates

被引:7
|
作者
Tefferi, A
Dingli, D
Li, CY
Mesa, RA
机构
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Hematopatol, Rochester, MN 55905 USA
关键词
myelofibrosis; microcytosis; prognosis; incidence; survival;
D O I
10.1016/j.leukres.2005.10.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Microcytosis is a characteristic laboratory feature for both iron deficiency anemia and thalassemia. It is also infrequently seen in "anemia of chronic disease" that accompanies a spectrum of chronic conditions including rheumatoid arthritis, polymyalgia rheumatica, diabetes mellitus, connective tissue disease, and protracted infection. In addition, there is a well established but pathogenetically obscure association of microcytosis with Hodgkin's lymphoma, Castleman's disease, and renal cell carcinoma. In the current study, we show that microcytosis is a frequent laboratory feature in agnogenic myeloid metaplasia and investigate its clinical relevance in the particular setting., (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:677 / 680
页数:4
相关论文
共 50 条
  • [1] SKIN MANIFESTATION OF AGNOGENIC MYELOID METAPLASIA
    LOEWY, G
    MATHEW, A
    DISTENFELD, A
    AMERICAN JOURNAL OF HEMATOLOGY, 1994, 45 (02) : 167 - 170
  • [2] Breast Cancer in a Patient with Agnogenic Myeloid Metaplasia
    Arik, Zafer
    Ozkan, Cigdem
    Ozdemir, Evren
    Altundag, Kadri
    SOUTHERN MEDICAL JOURNAL, 2010, 103 (10) : 1075 - 1076
  • [3] Agnogenic Myeloid Metaplasia: A Rare Cause of Ascites
    Sahinturk, Yasin
    Gokay, Arda
    Cekin, Ayhan Hilmi
    KUWAIT MEDICAL JOURNAL, 2014, 46 (03): : 253 - 255
  • [4] Autoimmune haemolytic anaemia as the presenting manifestation of agnogenic myeloid metaplasia
    Mohite, U
    Pathare, A
    Al Kindi, S
    Hiwase, D
    Vadakkepat, N
    Knox-Macaulay, H
    HAEMATOLOGIA, 2002, 32 (04) : 495 - 499
  • [5] SURVIVAL IN PRIMARY (IDIOPATHIC) OSTEOMYELOFIBROSIS, SO-CALLED AGNOGENIC MYELOID METAPLASIA
    THIELE, J
    KVASNICKA, HM
    STEINBERG, T
    ZANKOVICH, R
    FISCHER, R
    DIEHL, V
    LEUKEMIA & LYMPHOMA, 1992, 6 (4-5) : 389 - 399
  • [6] Idiopathic myelofibrosis (agnogenic myeloid metaplasia): Clinicopathological analysis of 32 patients
    Ozen, S
    Ferhanoglu, B
    Senocak, M
    Tuzuner, N
    LEUKEMIA RESEARCH, 1997, 21 (02) : 125 - 131
  • [7] Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia
    Arora, B
    Ho, CL
    Hoyer, JD
    Mesa, RA
    Tefferi, A
    HAEMATOLOGICA, 2004, 89 (12) : 1454 - 1458
  • [8] Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia - A simple CBC-based scoring system
    Dingli, D
    Schwager, SM
    Mesa, RA
    Li, CY
    Tefferi, A
    CANCER, 2006, 106 (03) : 623 - 630
  • [9] P16 gene deletions and point mutations in patients with agnogenic myeloid metaplasia (AMM)
    Wang, JC
    Chen, C
    LEUKEMIA RESEARCH, 1999, 23 (07) : 631 - 635
  • [10] Reduced expression of TGF β1RII in agnogenic myeloid metaplasia is not due to mutation or methylation
    Hemavathy, KC
    Chang, TH
    Zhang, HW
    Charles, W
    Goldberg, A
    Aithal, S
    Novetsky, AD
    Wang, JC
    LEUKEMIA RESEARCH, 2006, 30 (01) : 47 - 53